curtain raiser
Pratik Dattani,
Managing Director,
EPG Economic and
Strategy Consulting
Post-Brexit, the UK is increasingly
becoming a more interesting
people for Indian companies to explore,
because the depreciation of Sterling has
made UK investments more attractive.
Life sciences is an area that across
the UK there are leading hubs. Indian
companies traditionally have explored
just London, Cambridge and Oxford,
but Birmingham and Nottingham in the
Midlands and Scotland, as examples, all
have greater ecosystems for growth that
Indian companies should tap into.
with the event’s past editions.
The Public Health England’s Dr
S S Vasan, who is also Honorary
Visiting Professor at the University
of York, has been a regular speaker
at the bioConclave since inception.
On being asked why he is excited
about the event, Dr Vasan said:
“India’s frugal innovation (Jugaad)
combined with PHE, NHS and
wider UK plc could be a powerful
alliance leading to innovative
solutions for global health problems
such as anti-microbial resistance,
healthcare-acquired infections and
tuberculosis.”
“The bioConclave team has made
50
BioVoiceNews | July 2017
a dramatic impact in bringing
together the UK and Indian
life sciences and healthcare
communities, mentioned Rakesh
Roshan, CEO OxSight Limited,
an Oxford University venture,
who added, “In my role as CEO
of Oxford smart glasses spinout
OxSight I’m keenly aware of the
need make the most of position
in the Oxford and UK innovation
communities, and also to link
in to the global technology and
healthcare communities. India
is central to our plans, being
both a significant market and
a technology innovator and
manufacturer. In the two short
years that I’ve participated at